Avantor PE ratio AVTR

Share price divided by earnings per share over the last twelve months, since 2020.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 15.6×; Oct 2025
6-year median: 42.1×
6-year range: 11.5× to 369×
Peer median: 38.4×

Avantor has no meaningful PE ratio today: it lost $0.84 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Oct 2025, at 15.6×.

On the days it had one over the last 6 years, its median was 42.1×, from 11.5× in Aug 2025 to 369× in Apr 2021.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2025	15.6×	11.5×	48.4×
2024	46.5×	40.0×	64.1×
2023	42.3×	19.8×	42.6×
2022	22.4×	20.4×	47.7×
2021	53.3×	48.1×	369×
2020	217×	86.2×	217×

Against its peers

Companies in Medical - Diagnostics & Research nearest Avantor's size, closest first, today.

Company	PE ratio
AVTRAvantor	n/m
BIOBio-Rad Laboratories	44.8×
CAICaris Life Sciences	86.5×
RVTYRevvity	75.6×
MEDPMedpace	39.2×
LNTHLantheus	24.2×
LHLabcorp	27.2×
DGXQuest Diagnostics	25.7×
BLLNBillionToOne	166×
MTDMettler-Toledo International	37.6×
VCYTVeracyte	34.2×
Peer median	38.4×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Avantor

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.